Sign in
Taking people in United StatesNo phase

Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline

Key facts

Who runs it
University of Wisconsin, Madison
Where
Madison, United StatesSee the site
Trial code
Status
Recruiting
People taking part
55 people, planned
Started
13 Nov 2025
Expected to end
Jun 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Functional near-infrared spectroscopy (fNIRS)
  • V1 stimulation electrodes
  • Magnetic Resonance Imaging (MRI)
  • MAGNUS scanner
Record updated
4 November 2026

Who can take part

Age
20 years to 85 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Age 20-85 years
  • Willing and able to undergo all procedures
  • Free of any neurological (e.g., epilepsy, stroke, Parkinson's, brain tumors, moderate or severe traumatic brain injury), neuropsychiatric (e.g., schizophrenia, substance abuse, clinical depression), or developmental (e.g., autism, ADHD) or any other medical condition at the discretion of the PI and co-investigators
  • Age 20-65
  • Diagnosed with mild traumatic brain injury and be within 1-52 weeks post-injury
  • Willing and able to undergo all procedures

Who cannot take part

  • Known allergies to common electrode materials
  • Known allergies to common electrode materials
  • Candidates who have chronic infectious diseases (e.g. hepatitis, HIV, TB)
  • Candidates diagnosed with small vessel disease, vascular associated dementia (e.g. VCID), or renal disease
  • Candidates with neurological disorders other than those attributed to their primary diagnosis (e.g. MS, PD, ALS, AD or other dementia, uncontrolled pain)
  • Candidates with a history of seizures (except those in the acute or post-acute phases and are controlled)
  • Candidates currently on cardiovascular medications which, in the opinion of the investigators, would introduce a confounding factor to glymphatic system function (i.e. ACE-inhibitors, angiotensin receptor blockers, calcium channel blockers)
  • Contraindication to MRI
  • Contraindications for MRI
  • Candidates retinopathies or neuropathies that, in the opinion of the investigators, would prevent them from being able to complete the study or would introduce a confounding factor to glymphatic system function
  • Candidates who have had a penetrating injury, craniotomy (with the exception of a burr hole (trephination) for resolution of acute subdural hematoma), or refractory subdural hematoma
  • Candidates who experienced a loss of consciousness greater than 24 hours as a result of their TBI
  • Candidates who, in the opinion of the investigators, are unable to feel a sensory referred sensation from the stimulation or successfully complete the electrode placement and testing fNIRs

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 20 and 85 years old?

This trial is currently available in United States.

  • University of Wisconsin - MadisonMadison, United StatesContact: Kip Ludwig, PhD (principal investigator)Taking people

About the trial

What the trial wants to find out

The purpose of this research is to demonstrate that mild stimulation of a nerve (trigeminal nerve) in the head can modulate blood flow in the brain. The modulated blood flow will restore the flow of cerebrospinal fluid (CSF) and this in turn can help improve waste clearance in the brain and prevent build up that may lead to disease.

The 2 groups in the trial

  • Healthy ControlsExisting treatment, for comparison

    Treatment: Functional near-infrared spectroscopy (fNIRS), V1 stimulation electrodes, Magnetic Resonance Imaging (MRI), and MAGNUS scanner

  • Mild traumatic brain injury (mTBI)Existing treatment, for comparison

    Participants with recent mTBI

    Treatment: Functional near-infrared spectroscopy (fNIRS), V1 stimulation electrodes, and Magnetic Resonance Imaging (MRI)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07044596, who can take part
Record updated
4 November 2026